SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-055435
Filing Date
2020-10-20
Accepted
2020-10-20 20:48:32
Documents
1
Period of Report
2020-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4547
  Complete submission text file 0001209191-20-055435.txt   5919
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39612 | Film No.: 201249389

Mailing Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 415-993-8570
5:01 Acquisition Corp. (Issuer) CIK: 0001823465 (see all company filings)

IRS No.: 852790755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks